Stumbled across this stock by accident when I miss entered the ticker of another stock I was covering. I was intrigued by this stock and looked through a few of the previous announcements and did a TA on the chart. There is a compelling case to sway this to a buy. IMO there appears to be a good support at $0.08 supported by reasonable market depth, on the flip side a run to $0.12 would be easy to achieve before first big resistance test. I'm content with the cash position, and IMO I would feel comfortable to hold this stock over the next few months whilst the clinical study is underway. The argument is strengthened considerably as its covered by various analyst reports with price targets of circa $0.330 and $0.480.
Always looking for a reason not to buy a stock, so can some of the bears unleash your best work for me.
Regards D.
OSL Price at posting:
8.7¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)